Use of topiramate for glossodynia

被引:17
作者
Siniscalchi, Antonio
Gallelli, Luca
Marigliano, Norma Maria
Orlando, Paola
De Sarro, Giovambattista
机构
[1] Univ Magna Grecia Catanzaro, Dept Expt & Clin Med, Clin Pharmacol Unit, Mater Domini Hosp, I-88100 Catanzaro, Italy
[2] Annunziata Hosp, Dept Neurosci, Div Neurol, Cosenza, Italy
关键词
glossodynia; carbamazepine; gabapentin; topiramate;
D O I
10.1111/j.1526-4637.2006.00152.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Introduction. Glossodynia is a multifunctional disorder characterized by painful sensations in the mouth and throat and especially on the tongue. It is commonly cured by long-term therapy with systemic regimens of anxiolytics, antidepressants, and anticonvulsants. Case. We report here the case of a 65-year-old woman with a 4-month history of glossodynia. Clinical and laboratory evaluations performed the diagnosis of idiopathic glossodynia, and several treatments with carbamazepine and then with gabapentin induced the development of serious adverse reaction. Only treatment with topiramate has been able to induce a complete improvement of symptoms. Discussion. The pathogenesis of idiopathic glossodynia remains unclear, since it recently has been suggested as a possible neuropathic basis of burning mouth syndrome, demonstrating an altered excitability in the trigeminal nociceptive pathway at peripheral and/or central nervous system level. The various mechanisms of topiramate, which act at different neural transmission levels, blocking sodium and calcium channels, enhancing GABA concentration, and decreasing glutamate function at postsynaptic site, may explain the effects of topiramate in our patient. Conclusion. Therefore, we suggest that topiramate could represent a useful therapeutic option in the treatment of glossodynia.
引用
收藏
页码:531 / 534
页数:4
相关论文
共 29 条
  • [1] Psychological profile in burning mouth syndrome
    Al Quran, FAM
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2004, 97 (03): : 339 - 344
  • [2] Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus - A randomized controlled trial
    Backonja, M
    Beydoun, A
    Edwards, KR
    Schwartz, SL
    Fonseca, V
    Hes, M
    LaMoreaux, L
    Garofalo, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (21): : 1831 - 1836
  • [3] Topiramate relieves refractory intercostal neuralgia
    Bajwa, ZH
    Sami, N
    Warfield, CA
    Wootton, J
    [J]. NEUROLOGY, 1999, 52 (09) : 1917 - 1917
  • [4] Bergdahl M, 1999, J ORAL PATHOL MED, V28, P350
  • [5] Botha P J, 2001, SADJ, V56, P353
  • [6] Burning mouth syndrome: A review of etiologies
    Cibirka, RM
    Nelson, SK
    Lefebvre, CA
    [J]. JOURNAL OF PROSTHETIC DENTISTRY, 1997, 78 (01) : 93 - 97
  • [7] Eguia Del Valle Asier, 2003, Med Oral, V8, P84
  • [8] Sensory dysfunction in burning mouth syndrome
    Forssell, H
    Jääskeläinen, S
    Tenovuo, O
    Hinkka, S
    [J]. PAIN, 2002, 99 (1-2) : 41 - 47
  • [9] Topiramate in trigeminal neuralgia: A randomized, placebo-controlled multiple crossover pilot study
    Gilron, I
    Booher, SL
    Rowan, JS
    Max, MB
    [J]. CLINICAL NEUROPHARMACOLOGY, 2001, 24 (02) : 109 - 112
  • [10] BURNING MOUTH SYNDROME
    GRINSPAN, D
    BLANCO, GF
    ALLEVATO, MA
    STENGEL, FM
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 1995, 34 (07) : 483 - 487